ClinConnect ClinConnect Logo
Search / Trial NCT06278259

Telerehabilitation Program Bases Aerobic and Baduanjin Exercises in Post Stroke Elderly Patients

Launched by CAIRO UNIVERSITY · Feb 22, 2024

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating a new approach to help elderly patients recover after a stroke. It will involve 60 participants who will be randomly divided into two groups. One group will engage in a special Telerehabilitation program that includes gentle, rhythmic movements based on the Baduanjin exercise, which is a traditional Chinese practice. The other group will perform standard aerobic exercises. The goal is to see if the Baduanjin exercises help improve recovery and overall well-being compared to regular aerobic exercises.

To participate in this trial, individuals must be at least 65 years old and have been diagnosed with a stroke confirmed by brain imaging tests like a CT scan or MRI. They should also be stable in their health condition. However, people with certain conditions, such as severe vision or hearing issues, unstable heart conditions, or those currently involved in other rehabilitation studies, cannot participate. If enrolled, participants can expect to join guided exercise sessions via video, making it easier for them to follow along from home while contributing to important research in stroke recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * • The subject selection will be according to the following criteria:
  • All Patients of this study will be diagnosed as stroke and the diagnosis will be confirmed by computed tomography or MRI (El-Tamawy et al., 2021).
  • Age of patients will be more than or equal 65years (males and females).
  • All patients will be hemodynamically stable.
  • Exclusion Criteria:
  • * • The potential participants will be excluded if they meet one of the following criteria:
  • Patients who cannot follow instructions as sensory aphasia, blindness, dementia, and deafness.
  • Patients with any orthopedic, neurological, or chest disorders that affect trunk muscles control or cause respiratory disorders as COPD.
  • Patients with psychiatric disorders.
  • Patients with unstable cardiovascular conditions.
  • uncontrolled hypertension, or other concomitant respiratory diseases
  • participate at any research or rehabilitation program during the period of this study

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, Dokki, Egypt

Patients applied

0 patients applied

Trial Officials

marwa elsayed, PhD

Principal Investigator

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported